0000950170-25-080310.txt : 20250602 0000950170-25-080310.hdr.sgml : 20250602 20250602163013 ACCESSION NUMBER: 0000950170-25-080310 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250530 FILED AS OF DATE: 20250602 DATE AS OF CHANGE: 20250602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Altmeyer Anne CENTRAL INDEX KEY: 0001947086 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37348 FILM NUMBER: 251015425 MAIL ADDRESS: STREET 1: 500 RIVER RIDGE DRIVE CITY: NORWOOD STATE: MA ZIP: 02062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corbus Pharmaceuticals Holdings, Inc. CENTRAL INDEX KEY: 0001595097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 464348039 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 RIVER RIDGE DRIVE CITY: NORWOOD STATE: MA ZIP: 02062 BUSINESS PHONE: 617-963-0103 MAIL ADDRESS: STREET 1: 500 RIVER RIDGE DRIVE CITY: NORWOOD STATE: MA ZIP: 02062 FORMER COMPANY: FORMER CONFORMED NAME: SAV Acquisition Corp DATE OF NAME CHANGE: 20131220 4 1 ownership.xml 4 X0508 4 2025-05-30 0001595097 Corbus Pharmaceuticals Holdings, Inc. CRBP 0001947086 Altmeyer Anne C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 500 RIVER RIDGE DRIVE NORWOOD MA 02062 true false false false true Common Stock, par value $0.0001 per share 2025-05-30 4 S false 1392 7.2526 D 1391 D Common Stock, par value $0.0001 per share 2025-05-30 4 A false 4800 0 A 6191 D Stock options (right to buy) 7.42 2025-05-30 4 A false 16000 0 A 2035-05-30 Common Stock 16000 16000 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.16 to $7.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On May 30, 2025, 4,800 restricted stock units ("RSUs") were granted, which will be settled in shares of common stock, par value $0.0001. The RSUs will vest 100% on the one-year anniversary from the date of grant. This amount includes 4,800 unvested RSUs that were granted on May 30, 2025. The option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. The option will vest 100% on the one-year anniversary from the date of grant. /s/ Meghan Houghton, attorney-in-fact for Anne Altmeyer 2025-06-02